Clinical Trial Update: Adherence to PTH(1-84) Treatment (FP-002-IM)

View source ↗

Summary

This completed Takeda-sponsored trial FP-002-IM reports on adherence to PTH(1-84) therapy; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• NATPARA (parathyroid hormone (rhPTH 1-84))

Snippet

Sponsor: Takeda | Conditions: Clinical Use of PTH(1-84) | Status: COMPLETED | Results posted: 2014-05-28